4/A//SEC Filing
Truitt Joseph 4/A
Accession 0000899243-20-028608
CIK 0000875622other
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 4:15 PM ET
Size
6.5 KB
Accession
0000899243-20-028608
Insider Transaction Report
Form 4/AAmended
Truitt Joseph
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-05-28+100,000→ 100,000 totalExercise: $63.72Exp: 2030-05-28→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan (the "Plan").
- [F2]As previously reported on a Form 4 filed on May 29, 2020 by the reporting person, the reporting person reported acquiring stock options to purchase 130,000 shares of common stock. However, BioSpecifics Technologies Corp. (the "Company") subsequently determined that stock options to purchase 30,000 shares of common stock under the Plan were not validly granted pursuant to the Plan because they exceeded the Plan limit on the number of stock options that may be granted to any newly-hired employee participant in any one calendar year. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired.
- [F3]The stock options vest in four equal installments over the four-year period following the date of grant.
Documents
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeother
Related Parties
1- filerCIK 0001452429
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 18, 8:00 PM ET
- Accepted
- Oct 19, 4:15 PM ET
- Size
- 6.5 KB